Najjam Asghar serves as Executive at Sorrento Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Najjam Asghar has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 16, 2021 involved receiving (via award) 56,974 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 16, 2021 | SRNE | $0 | Award | 56,974 | $N/A | Discretionary |
Najjam Asghar currently holds 56,974 shares of Sorrento Therapeutics, Inc. (SRNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Najjam Asghar has been a net neutral trader of SRNE stock. They have purchased $0 and sold $0 worth of shares.
Najjam Asghar's most recent insider trade was on Mar 16, 2021, when they sold 56,974 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted